Hederagenin inhibits ferroptosis induced by the TGF-β/Smad3 signaling pathway in renal tubular cells by reducing NOX4 expression and increasing GPX4 expression, thereby improving fibrosis in diabetic nephropathy mouse models [207]. The gene discussed is GPX4; the disease is diabetic kidney disease.